Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 AraviveStrongbridge BiopharmaCannTrustGalectin TherapeuticsAdamas Pharmaceuticals
SymbolNASDAQ:ARAVNASDAQ:SBBPNYSE:CTSTNASDAQ:GALTNASDAQ:ADMS
Price Information
Current Price$8.94$3.26C$0.83$2.56$5.79
52 Week RangeBuyBuyHoldBuyHold
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyHold
Consensus Price Target$28.50$13.25C$4.50$11.00$15.67
% Upside from Price Target218.79% upside306.44% upside443.15% upside329.69% upside170.58% upside
Trade Information
Market Cap$142.98 million$186.47 millionC$118.93 million$153.02 million$158.37 million
Beta2.490.673.22.931.66
Average Volume110,908375,4461,380,287172,393226,377
Sales & Book Value
Annual Revenue$1.37 million$18.03 millionC$35.22 millionN/A$34.05 million
Price / Sales95.609.803.33N/A4.74
CashflowN/A$0.79 per shareN/AN/AN/A
Price / CashN/A4.11N/AN/AN/A
Book Value$5.36 per share$2.42 per shareC$1.27 per share($0.05) per share$3.29 per share
Price / Book1.671.350.65N/A1.76
Profitability
Net Income$-76,330,000.00$31.85 millionC$-10,460,000.00$-13,900,000.00$-131,000,000.00
EPS($10.64)$0.31C($0.11)($0.38)($4.87)
Trailing P/E RatioN/A4.72N/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A211.37%N/AN/A-215.09%
Return on Equity (ROE)-49.37%45.77%N/A-51.23%-205.30%
Return on Assets (ROA)-39.24%29.96%N/A-42.10%-52.94%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.18%N/AN/AN/A6.72%
Current Ratio7.59%4.24%N/A41.51%6.35%
Quick Ratio7.59%4.13%N/A41.51%6.15%
Ownership Information
Institutional Ownership Percentage30.34%49.78%23.64%16.67%51.84%
Insider Ownership Percentage39.80%5.10%N/A40.70%24.90%
Miscellaneous
Employees141065766159
Shares Outstanding14.65 million54.21 million141.49 million56.89 million27.86 million
Next Earnings Date3/5/2020 (Estimated)2/25/2020 (Confirmed)3/26/2020 (Estimated)3/4/2020 (Estimated)2/25/2020 (Confirmed)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel